Conference
Tezepelumab in Adults With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD): Efficacy and Safety From the Phase 2a COURSE Study
Authors
Singh D; Bafadhel M; Brightling CE; Rabe KF; Han MK; Bhutani M; Bourbeau J; Christenson SA; Dransfield MT; Nair P
Pagination
pp. a2782-a2782
Publisher
Oxford University Press (OUP)
Publication Date
May 1, 2024
DOI
10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a2782
Name of conference
A101. FULL METAL JACKET TARGETING COPD AND CHRONIC AIRWAYS DISEASE